Expertise in
10
conditions

Dr. Ayla A. Kessler

Oncology
Ashe Memorial Hospital
200 Hospital Ave, 
Jefferson, NC 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Expertise in
10
conditions
Ashe Memorial Hospital
200 Hospital Ave, 
Jefferson, NC 

Overview

Ayla Kessler is an Oncologist practicing medicine in Jefferson, North Carolina.

Dr. Kessler is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Breast Cancer, Inflammatory Breast Cancer, and Familial Colorectal Cancer.

She is actively involved in clinical research, participating in 7 clinical trials. Dr. Kessler is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in OH

Hospital Affiliations

Novant Health Forsyth Medical Center
North Carolina Baptist Hospital
Watauga Medical Center
Ashe Memorial Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health Plan
  • INSURANCE PLAN
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Ashe Memorial Hospital
200 Hospital Ave, Jefferson, NC 28640
Other Locations
Aspirus Rhinelander Hospital
2251 N Shore Dr, Rhinelander, WI 54501

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Prospective Observational Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Prospective Observational Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Enrollment Status: Recruiting
Publish Date: October 08, 2025
Intervention Type: Other, Drug
Study Drug: Carvedilol
Study Phase: Phase 3
A Randomized Phase III Post-operative Trial of Platinum Based Chemotherapy vs. Capecitabine in Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
A Randomized Phase III Post-operative Trial of Platinum Based Chemotherapy vs. Capecitabine in Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: July 27, 2026
Intervention Type: Drug
Study Drugs: Capecitabine, Carboplatin, Cisplatin
Study Phase: Phase 3
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: May 06, 2026
Intervention Type: Drug, Other
Study Drugs: Carboplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Paclitaxel
Study Phase: Phase 3
A Phase III Randomized Double-blind, Placebo Controlled Study of Alpelisib in Combination With Fulvestrant for Men and Postmenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment
A Phase III Randomized Double-blind, Placebo Controlled Study of Alpelisib in Combination With Fulvestrant for Men and Postmenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment
Enrollment Status: Completed
Publish Date: February 13, 2025
Intervention Type: Drug
Study Drugs: Fulvestrant, Alpelisib
Study Phase: Phase 3
An Open Label, Multi-center Protocol for U.S. Patients Enrolled in a Study of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negative, High Risk Early Breast Cancer
An Open Label, Multi-center Protocol for U.S. Patients Enrolled in a Study of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negative, High Risk Early Breast Cancer
Enrollment Status: Completed
Publish Date: October 11, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Randomized Multicenter Pivotal Study of CDX-011 (CR011-vcMMAE)in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer (The METRIC Study)
A Randomized Multicenter Pivotal Study of CDX-011 (CR011-vcMMAE)in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer (The METRIC Study)
Enrollment Status: Completed
Publish Date: March 08, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Phase 1/2 Open-Label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Seviteronel in Subjects With Advanced Breast Cancer
A Phase 1/2 Open-Label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Seviteronel in Subjects With Advanced Breast Cancer
Enrollment Status: Completed
Publish Date: February 01, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 6 Less Clinical Trials
Similar Doctors
Expertise in
12
conditions
Dr. Kim E. Nichols
Hematology | Oncology
Expertise in
12
conditions
Dr. Kim E. Nichols
Hematology | Oncology
Referral may be required
Before you request

ETSU Pediatrics- St. Jude's Clinic

400 N State Of Franklin Rd, Fl 1, 
Johnson City, TN 
 (52.2 miles away)
423-431-3950
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients
Offers Telehealth

Kim Nichols is a Hematologist and an Oncologist practicing medicine in Johnson City, Tennessee. Dr. Nichols is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, Reticulohistiocytoma, Histiocytosis, and Bone Marrow Transplant. Dr. Nichols is board certified in American Board Of Pediatrics. Dr. Nichols is currently accepting new patients.

Expertise in
31
conditions
Expertise in
31
conditions
Referral may be required

Atrium Health Wake Forest Baptist Wilkes Medical Center

1370 W D St, 
North Wilkesboro, NC 
 (24.9 miles away)
336-903-7900
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Anna Sobol is an Oncologist practicing medicine in North Wilkesboro, North Carolina. Dr. Sobol is highly rated in 31 conditions, according to our data. Her clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Paget Disease of the Breast, Lung Cancer, and Richter Syndrome. Dr. Sobol is currently accepting new patients.

Expertise in
15
conditions
Expertise in
15
conditions
Referral may be required

Iredell Physician Network LLC

365 Brookdale Dr, 
Statesville, NC 
 (54.2 miles away)
704-872-3630
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

William Petty is an Oncologist practicing medicine in Statesville, North Carolina. Dr. Petty is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Thymic Epithelial Tumor, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Advanced Bronchoscopy, and Bone Marrow Aspiration. Dr. Petty is currently accepting new patients.

Frequently Asked Questions about Dr. Ayla A. Kessler

How do I make an appointment with Dr. Ayla A. Kessler?

You can book an appointment with Dr. Ayla A. Kessler by calling their office at 336-277-7176. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ayla A. Kessler a top-rated expert for Angiosarcoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ayla A. Kessler is classified as an Advanced expert for Angiosarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ayla A. Kessler specialize in?

While Dr. Ayla A. Kessler is a Oncology, they have specific expertise in Angiosarcoma, Breast Cancer, and Inflammatory Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Ayla A. Kessler accept my insurance?

Dr. Ayla A. Kessler accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 336-277-7176 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kessler's expertise for a condition
ConditionClose
      View All 10 Advanced Conditions
      View All 61 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile